Used in cancer research, particularly in studies focused on DNA repair mechanisms. It is applied in the development of targeted therapies for cancers with specific genetic mutations, such as BRCA1 and BRCA2. This compound helps in understanding the efficacy of PARP inhibitors in treating ovarian, breast, and prostate cancers. It is also utilized in preclinical trials to assess its potential in enhancing the sensitivity of cancer cells to chemotherapy and radiation. Additionally, it aids in exploring resistance mechanisms to PARP inhibitors, contributing to the advancement of personalized medicine in oncology.